About (3S)-2-[(2R)-2-(cyclopentylmethyl)-3-[formyl(hydroxy)amino]propanoyl]-N-[2-(dimethylamino)pyrimidin-4-yl]pyrazolidine-3-carboxamide
(3S)-2-[(2R)-2-(cyclopentylmethyl)-3-[formyl(hydroxy)amino]propanoyl]-N-[2-(dimethylamino)pyrimidin-4-yl]pyrazolidine-3-carboxamide (PubChem CID 66546133) has the molecular formula C20H31N7O4
and a molecular weight of 433.51 g/mol. Its IUPAC name is (3S)-2-[(2R)-2-(cyclopentylmethyl)-3-[formyl(hydroxy)amino]propanoyl]-N-[2-(dimethylamino)pyrimidin-4-yl]pyrazolidine-3-carboxamide.
Molecular Properties
| Compound Name | (3S)-2-[(2R)-2-(cyclopentylmethyl)-3-[formyl(hydroxy)amino]propanoyl]-N-[2-(dimethylamino)pyrimidin-4-yl]pyrazolidine-3-carboxamide |
| PubChem CID | 66546133 |
| Molecular Formula | C20H31N7O4 |
| Molecular Weight | 433.51 g/mol |
| Exact Mass | 433.24 |
| IUPAC Name | (3S)-2-[(2R)-2-(cyclopentylmethyl)-3-[formyl(hydroxy)amino]propanoyl]-N-[2-(dimethylamino)pyrimidin-4-yl]pyrazolidine-3-carboxamide |
| SMILES | CN(C)c1nccc(NC(=O)[C@@H]2CCNN2C(=O)[C@H](CC2CCCC2)CN(O)C=O)n1 |
| InChI | InChI=1S/C20H31N7O4/c1-25(2)20-21-9-8-17(24-20)23-18(29)16-7-10-22-27(16)19(30)15(12-26(31)13-28)11-14-5-3-4-6-14/h8-9,13-16,22,31H,3-7,10-12H2,1-2H3,(H,21,23,24,29)/t15-,16+/m1/s1 |
| InChIKey | OMTXZJFPNYDIPP-CVEARBPZSA-N |
| XLogP | 0.63 |
| TPSA | 131.00 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
| MW ≤ 500 | 433.51 |
| LogP ≤ 5 | 0.63 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 8 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'aldehyde', 'substructure': 'N/A'}, {'alert_name': 'hydroxamic_acid', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'} |
|---|
Analyze (3S)-2-[(2R)-2-(cyclopentylmethyl)-3-[formyl(hydroxy)amino]propanoyl]-N-[2-(dimethylamino)pyrimidin-4-yl]pyrazolidine-3-carboxamide with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of (3S)-2-[(2R)-2-(cyclopentylmethyl)-3-[formyl(hydroxy)amino]propanoyl]-N-[2-(dimethylamino)pyrimidin-4-yl]pyrazolidine-3-carboxamide?
The IUPAC name of (3S)-2-[(2R)-2-(cyclopentylmethyl)-3-[formyl(hydroxy)amino]propanoyl]-N-[2-(dimethylamino)pyrimidin-4-yl]pyrazolidine-3-carboxamide (CID 66546133) is (3S)-2-[(2R)-2-(cyclopentylmethyl)-3-[formyl(hydroxy)amino]propanoyl]-N-[2-(dimethylamino)pyrimidin-4-yl]pyrazolidine-3-carboxamide.
What is the SMILES notation for (3S)-2-[(2R)-2-(cyclopentylmethyl)-3-[formyl(hydroxy)amino]propanoyl]-N-[2-(dimethylamino)pyrimidin-4-yl]pyrazolidine-3-carboxamide?
The canonical SMILES for (3S)-2-[(2R)-2-(cyclopentylmethyl)-3-[formyl(hydroxy)amino]propanoyl]-N-[2-(dimethylamino)pyrimidin-4-yl]pyrazolidine-3-carboxamide is CN(C)c1nccc(NC(=O)[C@@H]2CCNN2C(=O)[C@H](CC2CCCC2)CN(O)C=O)n1.
What is the InChIKey of (3S)-2-[(2R)-2-(cyclopentylmethyl)-3-[formyl(hydroxy)amino]propanoyl]-N-[2-(dimethylamino)pyrimidin-4-yl]pyrazolidine-3-carboxamide?
The InChIKey is OMTXZJFPNYDIPP-CVEARBPZSA-N. The full InChI is InChI=1S/C20H31N7O4/c1-25(2)20-21-9-8-17(24-20)23-18(29)16-7-10-22-27(16)19(30)15(12-26(31)13-28)11-14-5-3-4-6-14/h8-9,13-16,22,31H,3-7,10-12H2,1-2H3,(H,21,23,24,29)/t15-,16+/m1/s1.
What are the key properties of (3S)-2-[(2R)-2-(cyclopentylmethyl)-3-[formyl(hydroxy)amino]propanoyl]-N-[2-(dimethylamino)pyrimidin-4-yl]pyrazolidine-3-carboxamide?
(3S)-2-[(2R)-2-(cyclopentylmethyl)-3-[formyl(hydroxy)amino]propanoyl]-N-[2-(dimethylamino)pyrimidin-4-yl]pyrazolidine-3-carboxamide has a molecular weight of 433.51 g/mol, XLogP of 0.63, 9 rotatable bonds, 3 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for (3S)-2-[(2R)-2-(cyclopentylmethyl)-3-[formyl(hydroxy)amino]propanoyl]-N-[2-(dimethylamino)pyrimidin-4-yl]pyrazolidine-3-carboxamide is sourced from PubChem (CID 66546133), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).